The High-quality lactose products Made in the USA

Barentz has partnered with MEGGLE to distribute its pharmaceutical lactose range in the USA.

Barentz has established an exclusive partnership with MEGGLE to market & distribute its pharmaceutical lactose range in the USA. This collaboration allows customers to reduce lead time by locally sourcing a wide range of high-quality products that blend MEGGLE’s innovative offerings with Barentz’s well-established regional distribution capabilities.
MEGGLE, along with its manufacturing plant in Le Sueur, Minnesota, possesses adequate capacity to meet the pharmaceutical lactose requirements in the region. Some of their products made in the USA include Milled Lactose Monohydrate and Anhydrous Lactose.

Milled α-lactose monohydrate is a versatile ingredient in pharmaceutical manufacturing.

It offers the ability to modulate solid formulation properties such as compactibility, compressibility, porosity, and segregation tendency. It can be agglomerated to improve flowability, and its particle size and distribution can be optimized to suit a variety of applications.

MEGGLE offers a range of milled lactose grades to provide flexibility in tableting. It is commonly used in dry granulation procedures, extrusion/spheronization processes, and as a bulk substrate for fermentation in bio-industries. MEGGLE’s milled lactose grades suitable for wet and dry granulation are available under the trade names:
- GranuLac 70
- GranuLac 80
- GranuLac 140
- GranuLac 200
- GranuLac 230

Anhydrous Lactose Products

DuraLac H is well-suited for directly compressed and dry granulated formulations.

MEGGLE Anhydrous lactose DuraLac- H is produced by roller-drying a lactose solution at high temperature to form anhydrous beta-lactose and alpha-lactose crystals at levels approximating 70-80% and 20-30%, respectively. During beta-lactose crystallization, no water is incorporated in the crystal lattice resulting in lactose´s anhydrous form.

Subsequent to roller-drying, anhydrous lactose is milled and sieved to the desired particle size distribution, optimizing powder flow and compactibility. DuraLac H deforms by brittle fracture during compaction, it is well-suited for directly compressed and dry granulated formulations

At Barentz, we offer a complete excipient portfolio solution sourced from our pre-eminent partner suppliers. The objective is to ensure that each pharmaceutical manufacturer can find a suitable excipient that meets their specific requirements.